Pricing Log in Create free account

Cullinan Therapeutics, Inc. (CGEM) vs Jade Biosciences, Inc. (JBIO)

Cullinan Therapeutics, Inc. and Jade Biosciences, Inc. are both Biotechnology companies. Cullinan Therapeutics, Inc. and Jade Biosciences, Inc. are of similar size ($901.0M and $875.1M). Across the 8 metrics below, Jade Biosciences, Inc. leads on 7 and Cullinan Therapeutics, Inc. on 1.

Valuation

Metric CGEM JBIO Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 2.47 1.87 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (23.98%) (14.23%) (33.15%)
Free cash flow yield (20.03%) (15.03%) (25.50%)

Profitability

Metric CGEM JBIO Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (50.30%) (39.27%) (56.36%)
Return on assets (46.30%) (36.19%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CGEM JBIO Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (20.86%) 78.57% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CGEM JBIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.42 14.93 4.72
Net debt to EBITDA 1.57 2.94 0.96

Dividend

Metric CGEM JBIO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CGEM JBIO Biotechnology median
Market cap 900.97m 875.10m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack